GQIClass II
Antiserum, Cf, Cytomegalovirus
21 CFR 866.3175 / Microbiology
GQI is the FDA product code for Antiserum, Cf, Cytomegalovirus, a class II device type, regulated under 21 CFR 866.3175. As of , FDA records hold 18 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- GQI
- Device name
- Antiserum, Cf, Cytomegalovirus
- Regulation
- 21 CFR 866.3175
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 18
- Ingested recalls
- 0
Clearances, product code GQI
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1985 | 5 |
| 1986 | 5 |
| 1987 | 3 |
| 1988 | 1 |
| 1989 | 1 |
| 1994 | 1 |
| 1995 | 2 |
Applicants with the most clearances
Product code GQI| Applicant | Clearances |
|---|---|
| Amico Lab, Inc. | 2 |
| Gull Laboratories, Inc. | 2 |
| Labsystems, Inc. | 2 |
| Pyramid Biological Corp. | 2 |
| Behring Diagnostics, Inc. | 1 |
| Clinical Sciences, Inc. | 1 |
| Cordis US Corp. | 1 |
| Cytotech, Inc. | 1 |
| Diamedix Corp. | 1 |
| Electro-Nucleonics, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
